United Kingdom· GB-APID-36923611000001102
Refixia 1,000unit powder and solvent for solution for injection vials
A nonacog beta pegol product containing nonacog beta pegol, registered in United Kingdom by Novo Nordisk Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Nonacog beta pegol is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD36 (nonacog beta pegol), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Nonacog beta pegol · ATC B02BD36
2 / 19 countries
- Spainprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Nonacog beta pegol
- Manufacturer
- Novo Nordisk Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD36
- ATC class
- Nonacog beta pegol
- Defined daily dose
- 400 E, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5017954002184
- gtin5712249123994
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nonacog beta pegol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenRefixia 1000 IE Pulver och vätska till injektionsvätska, lösningNovo Nordisk A/S
- CanadaREBINYNNOVO NORDISK CANADA INC
- SwitzerlandRefixia 1000 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungNovo Nordisk Pharma AG
- CzechiaREFIXIANovo Nordisk A/S, Bagsvaerd
- SpainREFIXIA 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- FinlandRefixiaNovo Nordisk A/S
- IrelandRefixia 1 000 IU powder and solvent for solution for injectionNovo Nordisk A/S
- IcelandRefixiaNovo Nordisk A/S*
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Refixia
- Norway · Refixia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6a15927e-15a8-45a7-a4ce-934d5f264cc1 GET /v1/drugs/6a15927e-15a8-45a7-a4ce-934d5f264cc1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36923611000001102",
"desc": "Refixia 1,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "36932111000001101",
"source": "dmd",
"vtm_id": "776936007",
"strength": "1000 unit",
"substance": "Nonacog beta pegol",
"ingredient": "Nonacog beta pegol",
"supplier_code": "2080301000001101"
}See everything about nonacog beta pegol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.